Is Wesfarmers overvalued?

The conglomerate looks to have made some savvy moves recently but is it reflected in the share price already?

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Wesfarmers (ASX: WES) is a $50 billion giant conglomerate which has operations spanning retailing – including supermarkets (Coles), discount department stores (Target and Kmart), liquor, home improvement (Bunnings), office supplies (Officeworks) – coal mining, industrial and safety product distribution and chemicals and fertiliser manufacture.

In the past few weeks Wesfarmers has announced the sale of both its insurance division and its WA-based joint venture gas processing and supply business. These two sales will reduce the number of operating divisions of the group and return around $2 billion in cash to the company. While there is every chance some of this cash will be returned to shareholders, given the company's acquisitive nature and history of creating shareholder value there is a high chance much of this cash will be put towards value enhancing opportunities.

Despite the positive outlook for Wesfarmers' businesses, the strong performance of its share price over the past year has seen the stock rise from around $37.70 to $43.40 – a return of 16% – potentially making the stock expensive. That's certainly the opinion of analysts at research house Morningstar with the Australian Financial Review reporting that Morningstar has a long-term fair value of $37. Morningstar was positive on the sale of the insurance division, viewing the division as sub-scale and only "delivering low single-digit returns averaging 6.6 per cent during the last five years". However in their opinion this would appear to be more than reflected in the current share price.

Foolish takeaway

It's a difficult time for investors as we enter 2014 after a strong run-up in share prices. Wesfarmers is far from the only high quality business that looks to be trading at a full valuation. Other blue chips trading on hefty multiples compared to their earnings growth outlook include Woolworths (ASX:  WOW), CSL (ASX: CSL) and Coca-Cola Amatil (ASX: CCL). These high valuations could make it difficult for capital gains to be as strong in 2014 as in 2013.

Motley Fool contributor Tim McArthur does not own shares in any of the companies mentioned in this article.

More on ⏸️ Investing

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »

⏸️ Investing

Why Fox (NASDAQ:FOX) might hurt News Corp (ASX:NWS) shareholders

News Corporation (ASX: NWS) might be facing some existential threats from its American cousins over the riots on 6 January

Read more »